Global Continuous Glucose Monitoring System Market 2016-2022: Technology Leveraging - Key focus of partnerships Among industry players - Research and Markets
DUBLIN, May 10, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Continuous Glucose Monitoring System Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022" report to their offering.
Emergence of continuous glucose monitoring systems is a major breakthrough in the glucose monitoring for diabetic patients. Medtronic and Dexcom are the only major players in this industry followed by Abbott in few regions. Companies are focusing more on research and development before introducing their products in the market. CGMS are highly regulated and go through strict tests before being approved. CGM manufacturers have faced competition from self-monitoring blood glucose devices (SMBG). SMBG devices are cheaper and easy to use and have an less stringent approval process from authorities like FDA.
SMBG has more number of players and larger market share. However, CGM systems have been able to make a good market entry in the U.S. and are following the trend in other territories. CGM system market has seen good growth rates in past three years. Medtronic and Dexcom have introduced new systems which have witnessed lower frequency of errors. The MARD value for new sensors has decreased, new devices need lesser calibrations per day and most of the devices are approved for paediatric use. This has led to 50-60 percent jump in the revenues of some manufacturers.
Companies profiled include
1. Medtronic Inc.
2. Dexcom
3. Abbott
4. Johnson And Johnson (Animas Corp)
5. Insulet Corp
6. Tandem Diabetes
7. Echo Therapeutics
Key Topics Covered:
1. Executive Summary
2. Market Overview
2.1. What ARE CGMS?
2.2. Value Chain Analysis of the role of suppler, manufacturer, and end user in the CGMS market
2.2.1. Suppliers enabling financially weak players
2.2.2. Manufacturers facing regulations and operational cost issues
2.2.3. Pediatrics and hospitals will lead the future market growth
2.3. Key Buying Criteria
2.3.1. Convenience factor
2.3.2. Price is the key concern
2.3.3. Improved Accuracy leads to easier regulation norms
2.3.4. Collaboration of the two main manufacturers
2.3.5. Development of durable sensors
2.3.6. Development of APD
2.3.7. Focus on developing Asian markets
2.3.8. Partnerships and Collaborations - the winning strategies
2.3.9. Innovation Important for new entrants
3. Market Determinants
3.1. CGMS Market Motivators
3.1.1. Diabetes population rise leads to larger market opportunity
3.1.2. Rise in the global health expenditure and emerging Asian Market
3.1.3. Increased R&D funding for faster approvals and development of APD
3.1.4. Insulin Pump manufacturers willing to integrate CGMS and insulin pump technology
3.1.5. Private Insurers INCREASING CGMS AFFORDABILITY
3.1.6. New technology can bring down prices
3.2. RESTRAINTS
3.2.1. Government Regulations delaying the processes
3.2.2. Established SMBG DEVICE manufacturers restraining CGMS growth
3.2.3. Poor access to the healthcare services in developing markets
3.3. Opportunities
3.3.1. Growing diabetic population
3.3.2. Emergence of new segment - Pediatrics
3.3.3. Case study on pediatrics use
3.3.4. Development of artificial pancreas
3.4. Challenges in CGMS market
3.4.1. High Price
3.4.2. Unmet Diabetic needs
3.4.3. No government aid makes it difficult for the consumer
4. Sector Analysis: Diabetes Care
5. CGMS Market By devices
5.1. Long lasting Sensors: the need of the hour
5.2. Transmitters and receivers - The standalone system
5.3. Insulin Pumps hold the future
6. By Application
6.1. Professional CGMS (used by healthcare professionals)
6.1.1. Professional CGMS types
6.1.2. Case study on use of CGMS in hospital settings
6.1.3. Case study 2:Medtronic Real Time CGMS in rural Settings
6.1.4. Personal CGMS segmented on the basis of Age groups
7. Competitive Intelligence
7.1. Key Strategies to help CGMS market drive acceptance
7.1.1. Innovation The Key Industry to Overcome Competition
7.1.2. Technology Leveraging - Key focus of partnerships Among industry players
7.1.3. Product Launch - a make or break marketing strategy
7.1.4. Acquisitions Still Remain Niche in the CGMS Market
8. Market Share Analysis
8.1. Key Company Analysis
8.1.1. Dexcom
8.1.2. Medtronic
8.1.3. Abbott Diabetic Care
8.1.4. Market Share
8.1.5. Conclusion
9. Geographical Analysis
10. Corporate Profile: Benchmark Study
For more information visit http://www.researchandmarkets.com/research/4rmdn8/global_continuous
Media Contact:
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Share this article